MarkWide Research

Sale!

E-Prescribing Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 168
Delivery Format: PDF+ Excel

$2,950.00

Electronic Prescribing (E-prescribing) Market Statistics 2026

The market size for e-prescribing was estimated at $885.6 million as of 2018 and is predicted to reach $4,152.7 million in 2026. It is expected to grow at 21.4 percent from 2019 to 2026. E-prescribing software allows patients or users to send prescriptions electronically through their computers to their chosen pharmacies. The main goal of electronic prescribing models within HIT or EHR systems is efficient delivery and reception of accurate, complete, and clear prescriptions that optimize the process of processing and delivery, thereby ensuring that there are no interruptions to workflow or delays in the care of patients.

Healthcare professionals widely use electronic prescribing (E-prescribing) options for its benefits, such as increased patient safety, fewer errors in medication caused by handwritten prescriptions, fewer medication errors due to incorrectly interpreted prescriptions that are phoned in, and the less chance of losing or misplaced prescriptions. This is likely to increase the growth rate of the global e-prescribing industry in the coming years.

The hospital sector saw the most revenues in 2018 compared to all segments of the world electronic prescribing market and is predicted to continue this upward trend in the next years. This is due to the increase in the adoption of electronic prescribing and administration of medication systems that have benefits like precise communication between healthcare professionals and fewer adverse drug interactions as well as medication errors and the cost of healthcare.

North America has garnered high revenues due to its high acceptance of integrated e-prescription systems and increasing use of technologically advanced products for healthcare. This is one of the major factors driving the expansion of the forecast market for e-prescribing. Furthermore, since the people of the region are moving toward patient-focused solutions, the introduction of electronic prescriptions enables doctors in the region to deliver a high-quality experience without having to spend time visiting hospitals in non-urgent circumstances. At the same time, ambulatory care institutions across the region have adopted the e-prescribing solution at a high amount due to the favorable government policy toward public security. The above are reasons that are assisting the growth of the market for electronic prescriptions within the North American region.

The report concentrates on the potential for growth, the restraints, and market analyses. The study offers Porter’s Five Forces analysis for the industry of electronic prescriptions to comprehend the effects on various aspects like the power of bargaining among suppliers and competitors’ competitive strength and the threat of new competitors, the risk of substitutes, as well as bargaining power of the buyers in the market for electronic prescriptions.

Segment review

The market segmentation for electronic prescriptions is based on component deployment, the end-user, and the region. Each component it’s divided into solutions and services. Based on the deployment type, it’s separated into cloud and on-premise. Based on the end-user type and service, it is classified into office-based doctors, hospitals, and pharmaceuticals. The market by region is examined throughout North America, Europe, Asia-Pacific, and LAMEA.

Some key players operating in the global e-prescribing industry research comprise Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.

Top factors that impact

Various factors influence the market for electronic prescriptions in the world. Among them, beneficial incentive programs and initiatives by the government have seen a lot of traction and have significantly influenced the development of the industry. In addition, increased emphasis on reducing fraud and misuse of controlled substances in health institutions and the necessity to reduce the escalating health cost are among the primary factors that will drive the growth of this market over the next few years. However, the issues associated with the electronic health record (EHR) security of data and the complex workflow challenges associated with integrating e-prescribing in existing systems hinder the market’s growth to a certain degree. Additionally, the Asia-Pacific region is predicted to have a significant adoption rate for e-prescribing due to the ongoing development of healthcare infrastructure initiatives, which support technological advancements within the current systems.

Initiatives of the government and incentive programs

Initial initiatives of the government were about incorporating technologies in the healthcare sector to reduce the wait time for patients and facilitate service delivery. The advent of technological advancement in healthcare has shifted the focus to standardizing different technological advances, and the developing standards for electronic prescribing systems and their implementation gained significant speed over the last 10 years. This is one of the factors that will drive the market for e-prescribing in the coming forecast. In 2011, for instance in 2011, the U.S. Centers for Medicare and Medicaid Services introduced the Medicare and Medicaid EHR Incentive Programs that urged eligible hospitals and critical access hospitals and health care providers to install upgrades, implement (AIU) and demonstrate and implement the latest Certified EHR Technology (CEHRT).

The focus is on the prevention of fraud and misuse of substances controlled.

Electronic prescriptions’ use has been proven to increase efficiency through streamlining workflows for clinical practice across the healthcare system. Furthermore, these solutions also increase patient satisfaction by reducing the wait time in the pharmacies, enhancing patient compliance, and lowering the cost of medications to patients by automatically recommending effective generics and the best formulations. These are the key features that have aided in the expansion of the market and are anticipated to continue to generate high revenues in the coming years.

The Benefits to Stakeholders of HTML0:

  • This research includes the market opportunity for electronic prescribing and analysis, as well as trends and forecasts for the investment opportunities that are coming up.
  • The report contains information about the main drivers, constraints, and opportunities in the electronic prescriptions industry.
  • The market share of e-prescribing is measured quantitatively between 2018 and 2026 to show the financial competence of the sector.
  • Porter’s five forces analysis highlights the power of buyers and suppliers in the electronic prescribing market.

E-Prescribing Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

The Key Market Segments

  • By Component
    • Solutions
    • Services
  • End-User
    • Hospitals
    • Office-based Physicians
    • Pharmaceuticals
  • By Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
      • Poland
      • Russia
      • The Netherlands
      • Norway
      • Czech Republic
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Malaysia
      • Thailand
      • Singapore
      • Australia & New Zealand
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Colombia
      • Rest of South America
    • The Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Northern Africa
      • Rest of MEA
  • DEPLOYMENT
    • WEB – and CLOUD-BASED
    • ON-PREMISE

The Key Market Player

  • ALLSCRIPTS HEALTHCARE SYSTEMS, INC.
  • ATHENAHEALTH, INC.
  • CERNER CORPORATION
  • CHANGE HEALTHCARE
  • FIRST
  • ECLINICALWORKS
  • EPIC Systems Corporation
  • MedICAL INFORMATION TECHNOLOGY, INC.
  • PRACTICE FUSION, INC.
  • SURESCRIPTS

Table of Contents

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY

1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS

2.1.1. Top impacting factors
2.1.2. Top investment pockets

2.2. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs

3.4.2. Restraints

3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues

3.4.3. Opportunities

3.4.3.1. Growth in the developing countries across Asia-Pacific

3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET

CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT

4.1. OVERVIEW
4.2. SOLUTIONS

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. SERVICES

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT

5.1. OVERVIEW
5.2. WEB & CLOUD-BASED

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country

5.3. ON-PREMISE

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country

CHAPTER 6: E-PRESCRIBING MARKET, BY END USER

6.1. OVERVIEW
6.2. HOSPITALS

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country

6.3. OFFICE-BASED PHYSICIANS

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country

6.4. PHARMACEUTICALS

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country

CHAPTER 7: E-PRESCRIBING MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast, by region

7.2. NORTH AMERICA

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user

7.3. EUROPE

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user

7.3.5.2. UK

7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user

7.3.5.3. France

7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user

7.3.5.4. Rest of Europe

7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user

7.4.5.4. Rest of Asia-Pacific

7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country

7.5.5.1. Latin America

7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user

7.5.5.2. Middle East

7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user

7.5.5.3. Africa

7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS

8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration

8.4. PATENT ANALYSIS

8.4.1. By region (2016-2019)
8.4.2. By applicant

CHAPTER 9: COMPANY PROFILE

9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments

9.2. ATHENAHEALTH, INC.

9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments

9.3. CERNER CORPORATION

9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. CHANGE HEALTHCARE

9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments

9.5. DRFIRST

9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments

9.6. ECLINICALWORKS

9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments

9.7. EPIC SYSTEMS CORPORATION

9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments

9.8. MEDICAL INFORMATION TECHNOLOGY, INC.

9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments

9.9. PRACTICE FUSION, INC.

9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments

9.10. SURESCRIPTS

9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 20182026 ($MILLION)
TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 20182026 ($MILLION)
TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 20182026 ($MILLION)
TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 20182026 ($MILLION)
TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 20182026 ($MILLION)
TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 20182026 ($MILLION)
TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 20182026 ($MILLION)
TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 20182026 ($MILLION)
TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 20182026 ($MILLION)
TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 20182026 ($MILLION)
TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 20182026 ($MILLION)
TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 20182026 ($MILLION)
TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 20182026 ($MILLION)
TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 20182026 ($MILLION)
TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 20182026 ($MILLION)
TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 20182026 ($MILLION)
TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 20182026 ($MILLION)
TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 20182026 ($MILLION)
TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 20182026 ($MILLION)
TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 20182026 ($MILLION)
TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
TABLE 68. PARTNERSHIP (2016-2019)
TABLE 69. KEY EXPANSION (2016-2019)
TABLE 70. KEY ACQUISITION (2016-2019)
TABLE 71. COLLABORATION (2016-2019)
TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85. DRFIRST: KEY EXECUTIVES
TABLE 86. DRFIRST: COMPANY SNAPSHOT
TABLE 87. DRFIRST: PRODUCT PORTFOLIO
TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
TABLE 100. SURESCRIPTS: KEY EXECUTIVES
TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 20182026
FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 20182026
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 20182025
FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 20182026 ($MILLION)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 20182026 ($MILLION)
FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 20182026 ($MILLION)
FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
FIGURE 43. PATENT ANALYSIS, BY REGION
FIGURE 44. PATENT ANALYSIS, BY APPLICANT
FIGURE 45. R&D EXPENDITURE, 20162018 ($MILLION)
FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 20162018 ($MILLION)
FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. CERNER CORPORATION: REVENUE, 20162018 ($MILLION)
FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)

Major Companies

  • ALLSCRIPTS HEALTHCARE SYSTEMS, INC.
  • ATHENAHEALTH, INC.
  • CERNER CORPORATION
  • CHANGE HEALTHCARE
  • FIRST
  • ECLINICALWORKS
  • EPIC Systems Corporation
  • MedICAL INFORMATION TECHNOLOGY, INC.
  • PRACTICE FUSION, INC.
  • SURESCRIPTS

Major Segmentation

  • By Component
    • Solutions
    • Services
  • End-User
    • Hospitals
    • Office-based Physicians
    • Pharmaceuticals

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF